Reshma Kewalramani is the only person of Indian-origin to find her way to the 2025 list. Kewalramani emigrated to the United ...

Learn more about whether SoundHound AI, Inc. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, which ...

According to Benzinga Pro, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.62%, ...

TIME's 2025 list of the 100 Most Influential People includes global figures like Donald Trump and Muhammad Yunus in the ...

Under Reshma Kewalramani's leadership, Vertex achieved a major milestone with the FDA’s first-ever approval of a CRISPR-based ...

Morgan Stanley lowered the firm’s price target on Vertex (VERX) to $55 from $60 and keeps an Overweight rating on the shares. The firm is ...

Reshma is the kind of leader who can deliver that extraordinary future—it only seems crazy because no one’s done it before. I ...

Populix, an Indonesia-based market research tech startup, has netted USD 4.3 million in the first close of its Series B round ...

Vertex Pharmaceuticals has multiple growth drivers with potentially more on the way. Yo-yos are fun for kids. But yo-yo stock ...

Google Cloud's updated its Vertex AI platform to support AI agents with including the Agent Development Kit, the Agent2Agent ...

Vertex Inc. (NASDAQ: VERX) has expanded its Chief Strategy Office with the addition of Christopher Hall and Kathya Capote ...

Discover Google's new Veo-2 AI video generator transforming content creation with text-to-video and image-to-video ...